anmelden
BX Swiss TOP 30 CHF
1.428,93
PKT
+17,88
PKT
+1,27
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.07.12 | Novartis hold | Vontobel Research | |
| 27.07.12 | Logitech outperform | Exane-BNP Paribas SA | |
| 27.07.12 | Swiss Re neutral | Exane-BNP Paribas SA | |
| 27.07.12 | Roche outperform | Exane-BNP Paribas SA | |
| 27.07.12 | Logitech neutral | UBS AG | |
| 27.07.12 | ABB (Asea Brown Boveri) hold | Société Générale Group S.A. (SG) | |
| 27.07.12 | Logitech hold | Vontobel Research | |
| 26.07.12 | UBS hold | ING | |
| 26.07.12 | Sika neutral | Sarasin Research | |
| 26.07.12 | Logitech neutral | Sarasin Research | |
| 26.07.12 | ABB (Asea Brown Boveri) hold | ING | |
| 26.07.12 | Lonza neutral | UBS AG | |
| 26.07.12 | Straumann neutral | UBS AG | |
| 26.07.12 | Lonza hold | Vontobel Research | |
| 26.07.12 | Logitech hold | Vontobel Research | |
| 26.07.12 | Sika hold | Vontobel Research | |
| 26.07.12 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
| 25.07.12 | UBS outperform | Exane-BNP Paribas SA | |
| 25.07.12 | Lonza neutral | Sarasin Research | |
| 25.07.12 | UBS neutral | Nomura | |
| 25.07.12 | Novartis buy | Nomura | |
| 25.07.12 | Roche kaufen | Sarasin Research | |
| 25.07.12 | Novartis kaufen | Sarasin Research | |
| 25.07.12 | Swiss Re buy | Vontobel Research | |
| 25.07.12 | Lonza hold | Vontobel Research | |
| 25.07.12 | Holcim hold | Vontobel Research | |
| 24.07.12 | UBS neutral | Sarasin Research | |
| 24.07.12 | UBS hold | Commerzbank Corp. & Markets | |
| 24.07.12 | Julius Bär equal-weight | Morgan Stanley | |
| 24.07.12 | Swiss Re neutral | Nomura | |
| 24.07.12 | Swiss Life buy | Nomura | |
| 23.07.12 | Julius Bär buy | Sarasin Research | |
| 23.07.12 | Julius Bär buy | ING | |
| 23.07.12 | Holcim buy | Société Générale Group S.A. (SG) | |
| 23.07.12 | UBS neutral | UBS AG | |
| 23.07.12 | Novartis hold | Vontobel Research | |
| 23.07.12 | Julius Bär hold | Vontobel Research | |
| 23.07.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 20.07.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 20.07.12 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) |